RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to the Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/22/12 | undisclosed |
Telegraph Hill Group | undisclosed | |
| 06/27/24 | $20,000,000 | Venture |
5AM Ventures Agilent Technologies Arboretum Ventures  F-Prime Capital Partners Forest Road Company GKCC HealthQuest Capital Ron Seubert Sheatree Capital | undisclosed |
